Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Neurology
  4. The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism

The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism

Molecular Neurobiology, 2020 · DOI: https://doi.org/10.1007/s12035-019-01731-5 · Published: August 30, 2019

NeurologyGenetics

Simple Explanation

PPARGC1A encodes PGC-1α, a transcriptional co-activator involved in multiple transcriptional programs, including those relevant to neurodegenerative diseases. The study identifies CNS-specific transcripts of PPARGC1A and examines how their expression is regulated in neuronal cells. A variable GT repeat polymorphism in the CNS promoter region influences promoter activity, and hypoxia also regulates CNS-specific transcript expression.

Study Duration
Not specified
Participants
Human neuronal cell lines, rat model of ischemia, DNA from 2000 subjects
Evidence Level
Not specified

Key Findings

  • 1
    A naturally occurring variable GT repeat polymorphism increases promoter activity in neuronal cell lines.
  • 2
    The CNS promoter is induced by FOXA2 and co-activated by PGC-1α, resulting in robust activation.
  • 3
    The CNS promoter is targeted by the canonical hypoxia response involving HIF1A, modulated by the size of the GT polymorphism.

Research Summary

This study investigates the regulation of CNS-specific PPARGC1A transcripts in human neuronal cell lines and a rat model of ischemia. The findings reveal that a GT repeat polymorphism and hypoxia influence the expression of these transcripts, suggesting a role in ischemia. The study also identifies FOXA2 as a selective activator of the CNS-specific promoter, further highlighting its role in neuronal function.

Practical Implications

Inter-individual Variability

The GT repeat polymorphism may explain inter-individual variability in CNS transcript expression and response to hypoxia.

Therapeutic Target

Understanding the regulation of CNS-specific PPARGC1A transcripts could lead to new therapeutic targets for neurodegenerative diseases and ischemia.

Dopaminergic Neuron Maintenance

FOXA2's role in activating the CNS-specific promoter suggests a link to the development and maintenance of dopaminergic mid-brain neurons.

Study Limitations

  • 1
    The study primarily used cell lines and a rat model; further studies in humans are needed.
  • 2
    The precise mechanisms of interaction between HIF1A and the GT repeat size require further investigation.
  • 3
    The effects of ischemia on individual brain regions need further study due to limited sample numbers.

Your Feedback

Was this summary helpful?

Back to Neurology